Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov 8;11(11):2064.
doi: 10.3390/diagnostics11112064.

Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy

Affiliations
Case Reports

Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy

Sunha Park et al. Diagnostics (Basel). .

Abstract

Immune-mediated necrotizing myopathy, a new subgroup of inflammatory myopathies, usually begins with subacute onset of symmetrical proximal muscle weakness. A 35-year-old male presented with severe asymmetric iliopsoas atrophy and low back pain with a previous history of left lower extremity weakness. Although his first left lower extremity weakness occurred 12 years ago, he did not receive a clear diagnosis. Magnetic resonance imaging of both thigh muscles showed muscle edema and contrast enhancement in patch patterns, and the left buttock and thigh muscles were more atrophied compared to the right side. Serum creatine kinase levels were elevated, and serologic testings were all negative. Genetic testing using a targeted gene-sequencing panel for neuromuscular disease including myopathy identified no pathogenic variants. Muscle biopsy on the right vastus lateralis showed scattered myofiber necrosis with phagocytosis and an absence of prominent inflammatory cells, consistent with seronegative necrotizing myopathy. Thus, unusual asymmetric muscle weakness and atrophy can be a manifestation of inflammatory myopathy.

Keywords: asymmetric muscle involvement; immune-mediated necrotizing myopathy; inflammatory myopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Magnetic resonance imaging (MRI) of the lumbar region. Left iliopsoas muscle atrophy (white arrowhead) compared to the right side (star point) observed on lumbar MRI at the time of the initial visit.
Figure 2
Figure 2
Results of magnetic resonance imaging (MRI) T1-dissusion (A) and T1-fat suppression (B) images of both thighs demonstrated diffuse high signal intensities on both thigh muscles (white arrows) and atrophy in the left buttock and thigh muscles.
Figure 3
Figure 3
Muscle biopsy from the right vastus lateralis (A) Necrotic tissue infiltrated by macrophages (immunohistochemistry, CD68 stain) (×400) (B) Scant endomysial infiltration of CD4+ T-lymphocytes (arrows) (immunohistochemistry, CD4 stain) (×200) (C) Scattered necrotic myofibers (arrowhead) (×400) (D) with phagocytosis (white arrows) (high power field, Hematoxylin and eosin stain) (×200).

Similar articles

References

    1. Allenbach Y., Benveniste O., Stenzel W., Boyer O. Immune-mediated necrotizing myopathy: Clinical features and pathogenesis. Nat. Rev. Rheumatol. 2020;16:689–701. doi: 10.1038/s41584-020-00515-9. - DOI - PubMed
    1. Allenbach Y., Mammen A.L., Benveniste O., Stenzel W. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul. Disord. 2018;28:87–99. doi: 10.1016/j.nmd.2017.09.016. - DOI - PubMed
    1. Selva-O’Callaghan A., Pinal-Fernandez I., Trallero-Araguás E., Milisenda J.C., Grau-Junyent J.M., Mammen A.L. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018;17:816–828. doi: 10.1016/S1474-4422(18)30254-0. - DOI - PMC - PubMed
    1. Lim J., Rietveld A., De Bleecker J.L., Badrising U.A., Saris C.G.J., van der Kooi A.J., de Visser M. Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy. Neurol. Neuroimmunol. Neuroinflamm. 2019;6:e513. doi: 10.1212/NXI.0000000000000513. - DOI - PMC - PubMed
    1. Park J., Oh H.M., Park H.J., Cho A.R., Lee D.W., Jang J.H., Jang D.H. Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients. Mol. Genet. Genom. Med. 2019;7:e00947. doi: 10.1002/mgg3.947. - DOI - PMC - PubMed

Publication types

LinkOut - more resources